Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Jul 1996, 371-373, Vol 3, No. 4
MW Moss, AV Carella, V Provost and TC Quinn
Currently, CD4+ lymphocyte counts are one of the most widely used surrogate
markers for monitoring disease progression in and initiating therapy for
human immunodeficiency virus-infected individuals. However, the process of
obtaining lymphocyte subset counts can be complex and expensive, often
rendering the test inaccessible to many patients. In contrast to standard
laser-based flow cytometry, the TRAx CD4 Test Kit utilizes an enzyme-linked
immunoassay format to provide CD4+ lymphocyte counts by a simple and more
cost-effective means. In order to evaluate the utility of the TRAx CD4+
assay in comparison with flow cytometry, heparinized blood samples were
drawn from 188 infected and uninfected adult patients and 24 infected
pediatric patients and evaluated by both assays. The correlation
coefficient for all adult individuals tested was 0.94, and the mean
absolute counts (in cells per milliliter, +/- standard deviation) were 510
+/- 358 for TRAx and 480 +/- 361 for flow cytometry. The correlation for
the pediatric group was 0.93, with mean absolute counts of 956 +/- 767 for
TRAx and 1,521 +/-a 1,438 for flow cytometry. Overall the TRAx CD4 Test Kit
performed well in comparison to flow cytometry, and its lower cost and ease
of use make it an encouraging alternative for the routine determination of
CD4+ lymphocyte counts.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |